Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −12.4%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
Follow SYK
Alert me
Stryker Corporation (SYK) Current ratio
Stryker Corporation's current ratio at the end of the quarter to 30 September 2026 was 2.2×, up 0.3× from fiscal 2025 (1.9×). Over the past ten years it has ranged from 1.6× (fiscal 2023) to 2.5× (fiscal 2019); the current reading is higher than 27% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.9× | (2.89%) |
| FY2024 | 1.9× | 23.35% |
| FY2023 | 1.6× | (3.05%) |
| FY2022 | 1.6× | (25.97%) |
| FY2021 | 2.2× | 14.35% |
| FY2020 | 1.9× | (23.38%) |
| FY2019 | 2.5× | 24.12% |
| FY2018 | 2.0× | (11.72%) |
| FY2017 | 2.3× | (8.15%) |
| FY2016 | 2.5× | 10.10% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 2.2× | 1.15% |
| Jun 2026 | 2.2× | 2.13% |
| Mar 2026 | 2.1× | 11.57% |
| Dec 2025 | 1.9× | 2.37% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| EW Edwards Lifesciences Corporation compare | 4.6× |
| SYK Stryker Corporation | 2.2× |
| MDT Medtronic PLC compare | 2.1× |
| STE STERIS plc compare | 2.1× |
| DXCM DexCom, Inc. compare | 1.7× |
| ABT Abbott Laboratories compare | 1.4× |
| BSX Boston Scientific Corporation compare | 1.4× |
| PHG Koninklijke Philips N.V. compare | 1.3× |
| GEHC GE HealthCare Technologies Inc. compare | 1.3× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement